The relationship between EGFR and/or ErbB2 overexpression, MAPK hyperactivation, NF-κB transcriptional activity and loss of ER protein expression in Basal-like or ErbB2-overexpressing breast tumours is currently under investigation. The gene discussed is EGFR; the disease is breast neoplasm.